Concepedia

Ina Sulkaj

IS

Statistics

Publications

5

Citations

345

H-Index

5

Active since

2020

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Massachusetts Institute of Technology

Massachusetts General Hospital

Ragon Institute of MGH, MIT and Harvard

Ina Sulkaj is an author at Brigham and Women's Hospital specializing in tumor immunology, immunomodulation, and t cell immunity.

ORCID

Top concepts

Publications per year

2020–2023

5

Publications

5

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

Leyuan Ma, Alexander Hostetler, Duncan M. Morgan et al. · Cell · 2023 · 175 citations · Full text

, , +24

Regulatory T cells engineered with TCR signaling–responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter

Siawosh K. Eskandari, Ina Sulkaj, Mariane B. Melo et al. · Science Translational Medicine · 2020 · 95 citations · Full text

Increased Dopamine Type 2 Gene Expression in the Dorsal Striatum in Individuals With Autism Spectrum Disorder Suggests Alterations in Indirect Pathway Signaling and Circuitry

Cheryl Brandenburg, Jean‐Jacques Soghomonian, Kunzhong Zhang et al. · Frontiers in Cellular Neuroscience · 2020 · 33 citations · Full text

Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts

John Y. Choi, Siawosh K. Eskandari, Songjie Cai et al. · Proceedings of the National Academy of Sciences · 2020 · 31 citations · Full text

mTORC1 Inhibition Protects Human Regulatory T Cells From Granzyme-B-Induced Apoptosis

Siawosh K. Eskandari, Hazim Allos, Basmah S. Al Dulaijan et al. · Frontiers in Immunology · 2022 · 11 citations · Full text

1–5 of 5